central nervous system

Switching from a regimen containing abacavir/lamivudine or emtricitabine/tenofovir disoproxil fumarate to emtricitabine/tenofovir alafenamide fumarate does not affect central nervous system HIV-1 infection

Authors: Aylin Yilmaz, Åsa Mellgren, Dietmar Fuchs, Staffan Nilsson, Kaj Blennow, Henrik Zetterberg & Magnus Gisslén

Journal: Infectious Diseases

Year Published: 2019

Background: Despite suppressive antiretroviral therapy (ART), many HIV-infected individuals have low-level persistent immune activation in the central nervous system (CNS). There have been concerns regarding the CNS efficacy of tenofovir alafenamide fumarate (TAF) because of its […]

Does acute hepatitis C infection affect the central nervous system in HIV-1 infected individuals?

Authors: A Winston, L Garvey, E Scotney, D Yerrakalva, J M Allsop, E C Thomson, V P B Grover, J Main, J I Cox, M Wylezinska, S D Taylor-Robinson

Journal: Journal of Viral Hepatitis

Year Published: 2010

Central nervous system (CNS) manifestations of chronic hepatitis C virus (HCV) and chronic human immune deficiency virus-1 (HIV-1) infections have been reported, but the impact of acute HCV infection on the CNS is unknown. A total […]

Back to Publications